[1]石 沁,欧阳红梅,宋建新.慢性淋巴细胞白血病患者骨髓INF-γ、IL-2、IL-4、IL-10及IL-1β水平的变化及意义[J].医学信息,2018,31(17):149-151.[doi:10.3969/j.issn.1006-1959.2018.17.047]
 SHI Qin,OUYANG Hong-mei,SONG Jian-xin.Changes and Significance of IFN-γ,IL-2,IL-4,IL-10 and IL-1β in Marrow of Patients with Chronic Lymphocytic Leukemia[J].Journal of Medical Information,2018,31(17):149-151.[doi:10.3969/j.issn.1006-1959.2018.17.047]
点击复制

慢性淋巴细胞白血病患者骨髓INF-γ、IL-2、IL-4、IL-10及IL-1β水平的变化及意义()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年17期
页码:
149-151
栏目:
诊疗技术
出版日期:
2018-09-01

文章信息/Info

Title:
Changes and Significance of IFN-γ,IL-2,IL-4,IL-10 and IL-1β in Marrow of Patients with Chronic Lymphocytic Leukemia
文章编号:
1006-1959(2018)17-0149-03
作者:
石 沁1欧阳红梅2宋建新2
1.云南省临沧市云县人民医院检验科,云南 云县 675800; 2.云南省第一人民医院血液学诊断室,云南 昆明 650032
Author(s):
SHI Qin1OUYANG Hong-mei2SONG Jian-xin2
1.Department of Clinical Laboratory,Yunxian People's Hospital,Yunxian 675800,Yunnan,China; 2.Hematology Diagnosis Room,the First People's Hospital of Yunnan Province,Kunming 650032,Yunnan,China
关键词:
慢性淋巴细胞白血病骨髓细胞因子
Keywords:
Key words:Chronic lymphocytic leukemiaMarrowCytokines
分类号:
R733.72
DOI:
10.3969/j.issn.1006-1959.2018.17.047
文献标志码:
A
摘要:
目的 探讨CLL患者骨髓中INF-γ、IL-2、IL-4、IL-10及IL-1β水平的变化及意义。方法 选取我院初诊CLL患者66例为病例组,根据Binet分期分为BinetA期29例,BinetB期21例,BinetC期16例;选取同期来我院健康体检者30例为对照组,另取38例治疗中的CLL患者为治疗组。应用流式细胞仪分析各组患者骨髓INF-γ、IL-2、IL-4、IL-10、IL-1β表达,观察在CLL患者不同时期的表达差异。结果 IFN-γ、IL-2表达在CLL各组中均低于对照组(P<0.05),而BinetC期患者表达低于BinetB期(P<0.05),BinetB期低于BinetA期(P<0.05),与Binet分期呈负相关。INF-γ、IL-2在CLL治疗后虽高于BinetA期,但P>0.05,而低于对照组(P<0.05)。IL-4、IL-10、IL-1β表达高于对照组(P<0.05),BinetB期高于BinetA期(P<0.05),BinetC期高于BinetB期(P<0.05),与Binet分期呈正相关。治疗后IL-4、IL-10、IL-Iβ与BinetA期比较有所降低,但P>0.05,与对照组比较仍高于对照组(P<0.05)。结论 CLL患者骨髓微环境细胞因子表达紊乱,Th1类细胞因子INF-γ、IL-2随着CLL Binet分期的进展逐渐减低,IL-4、IL-10、IL-1β则逐渐增高,与CLL的发生、发展相关。
Abstract:
Abstract:Objective To investigate the changes and significance of INF-γ,IL-2,IL-4,IL-10 and IL-1β in marrow of CLL patients.Methods 66 patients with newly diagnosed CLL in our hospital were selected as the case group.According to Binet stage,there were 29 cases of BinetA stage,21 cases of BinetB stage and 16 cases of BinetC stage.30 cases of healthy physical examination in our hospital were selected as control group.The CLL patients in the treatment group were the treatment group.Another 38 patients with CLL under treatment were treated.The expressions of INF-γ,IL-2,IL-4,IL-10 and IL-1β in marrow of each group were analyzed by flow cytometry,and the expression differences in different periods of CLL patients were observed.Results The expressions of IFN-γ and IL-2 in CLL group were lower than those in control group(P<0.05),while those in BinetC stage were lower than BinetB stage(P<0.05),and BinetB stage was lower than BinetA stage(P<0.05),negatively correlated with Binet staging.INF-γ and IL-2 were higher than the BinetA phase after CLL treatment,but P>0.05,which was lower than the control group(P<0.05).The expressions of IL-4, IL-10 and IL-1β were higher than those of the control group(P<0.05),the BinetB phase was higher than the BinetA phase(P<0.05), the BinetC phase was higher than the BinetB phase(P<0.05),positively correlated with Binet staging.After treatment,IL-4,IL-10,IL-Iβ and BinetA phase were decreased,but P>0.05,which was still higher than the control group(P<0.05).Conclusion The expression of cytokines in bone marrow microenvironment of patients with CLL is disordered.The cytokines of Th1 type cytokines INF-γ and IL-2 decrease with the progression of CLL Binet stage,and IL-4,IL-10 and IL-1β gradually increase,and CLL occurrence and development are related.

参考文献/References:

[1]Hojjat-Farsangi M,Jeddi-Tehrani M,Razavi SM,et al.Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia[J].Cancer Sci,2009,100(12):2346-2353. [2]D'Arena G,Simeon V,Auria F,et al.Regulatory T-cells in chronic lymphocytic leukemia:actor or innocent bystander[J].Am J Blood Res,2013,3(1):52-57. [3]中华医学会血液学分会.中国慢性淋巴细胞白血病的诊断与治疗指南(2011年版)[J].中华血液学杂志,2011,32(7):498-501. [4]Kiaii S,Kokhaei P,Mozaffari F,et al.T cells from indolent CLL patients apoptosis of leukemic B cells in vitro and have altered gene expression profile[J].Cancer Immunol Immunother,2013,62(1):51-63. [5]姜焕好,曾东良,吴春凤,等.急性白血病患者治疗前后血清 INF-γ、VEGF、IL-10及IL-12水平的变化及意义[J].医学综述,2012,1(2):299-300. [6]宋建新,张芹,梅芬,等.慢性粒细胞白血病患者骨髓部分细胞因子的表达及意义[J].国际检验医学杂志,2016,12(23):3255-3257. [7]宋建新,欧阳红梅,闻艳,等.慢性粒细胞白血病骨髓巨噬细胞表达与细胞因子的相关性[J].广东医学,2017,3(5):1-5. [8]Mainou-Fowler T,Miller S,Proctor SJ,et al.The levels of TNF alpha,IL-4 andIL-10 production by T-cells in B-cell chronic lymphocytic leukaemia(B-CLL)[J].Leuk Res,2001,25(2):157-163. [9]Mantovani A,Garlanda C,Allavena P.Molecular path-ways and targets in cancer-related inflammation[J].Ann Med,2010,42(3):161-170.

相似文献/References:

[1]石 沁,欧阳红梅,宋建新.血液病患者骨髓微环境和外周血部分细胞因子水平的对比[J].医学信息,2019,32(13):81.[doi:10.3969/j.issn.1006-1959.2019.13.022]
 SHI Qin,OUYANG Hong-mei,SONG Jian-xin.Comparison of Bone Marrow Microenvironment and Peripheral Blood Cytokine Levels in Patients with Hematological Diseases[J].Journal of Medical Information,2019,32(17):81.[doi:10.3969/j.issn.1006-1959.2019.13.022]
[2]刘鹏江,邓 琦.伊布替尼治慢性淋巴细胞白血病的研究[J].医学信息,2020,33(22):48.[doi:10.3969/j.issn.1006-1959.2020.22.015]
 LIU Peng-jiang,DENG Qi.Research of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia[J].Journal of Medical Information,2020,33(17):48.[doi:10.3969/j.issn.1006-1959.2020.22.015]

更新日期/Last Update: 2018-09-01